Intuitive Surgical, Inc. Stock

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-05-31 pm EDT 5-day change 1st Jan Change
402.1 USD -0.31% Intraday chart for Intuitive Surgical, Inc. -0.67% +19.20%
Sales 2024 * 8.03B Sales 2025 * 9.32B Capitalization 143B
Net income 2024 * 1.97B Net income 2025 * 2.27B EV / Sales 2024 * 17.1 x
Net cash position 2024 * 5.19B Net cash position 2025 * 7.75B EV / Sales 2025 * 14.5 x
P/E ratio 2024 *
73.5 x
P/E ratio 2025 *
63.5 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.44%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.31%
1 week-0.67%
1 month+8.18%
3 months+1.06%
6 months+27.58%
Current year+19.20%
More quotes
1 week
396.15
Extreme 396.151
412.29
1 month
378.87
Extreme 378.87
412.29
Current year
320.26
Extreme 320.26
412.29
1 year
254.85
Extreme 254.85
412.29
3 years
180.07
Extreme 180.07
412.29
5 years
120.17
Extreme 120.1667
412.29
10 years
40.89
Extreme 40.8911
412.29
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
President 56 96-02-29
Director of Finance/CFO 52 13-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-03-31
Director/Board Member 66 07-10-18
Director/Board Member 71 10-03-31
More insiders
Date Price Change Volume
24-05-31 402.1 -0.31% 1,983,052
24-05-30 403.4 +1.25% 1,651,082
24-05-29 398.4 -0.66% 958,223
24-05-28 401 -0.94% 964,207
24-05-24 404.8 +1.62% 1,082,160

Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
402.1 USD
Average target price
423.6 USD
Spread / Average Target
+5.33%
Consensus